# Novel Laboratories, Inc. d.b.a Lupin Somerset – FDA Inspection, Feb 23, 2018

Source: https://www.keypedia.com/records/fda_inspections/novel-laboratories-inc-dba-lupin-somerset/f74654d7-0457-44a8-9e57-74a0152e90f7
Source feed: FDA_Inspections

> FDA inspection 1042022 of Novel Laboratories, Inc. d.b.a Lupin Somerset, February 23, 2018. Classification: Voluntary Action Indicated (VAI). 4 citations under 21 CFR part 211. Form 483 issued. 18 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1042022
- Company Name: Novel Laboratories, Inc. d.b.a Lupin Somerset
- Inspection Date: 2018-02-23
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 4

## Related Documents

- [FDA Inspection 1306616 - 2026-04-17](https://www.keypedia.com/records/fda_inspections/novel-laboratories-inc-dba-lupin-somerset/3929d635-0f63-4a0a-b47f-d35102bc3d33)
- [FDA Inspection 1285934 - 2025-10-10](https://www.keypedia.com/records/fda_inspections/novel-laboratories-inc-dba-lupin-somerset/68e0ace3-c682-4a1c-bb76-34bb3f2712bd)
- FDA Inspection 1259938 - 2025-01-31
- [FDA Inspection 1235495 - 2024-05-17](https://www.keypedia.com/records/fda_inspections/novel-laboratories-inc-dba-lupin-somerset/da7fdbc2-3b68-4bd4-bebb-447e90336803)
- [FDA Inspection 1197049 - 2023-01-13](https://www.keypedia.com/records/fda_inspections/novel-laboratories-inc-dba-lupin-somerset/c29bdd8e-f68a-4554-b27f-a094c6c578d0)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/nancy-m-espinal/f4494790-6a37-4998-853c-f859a0eb3330)
- [Sena G. Dissmeyer](https://www.keypedia.com/people/sena-g-dissmeyer/4dbb1255-95e4-402b-8bb3-75c4f7940c13)

Company: https://www.keypedia.com/companies/novel-laboratories-inc-dba-lupin-somerset/53a42119-c077-49fb-b739-db29c2b99391

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c